To determine men's attribution of fault for adverse consequences of prostate-specific antigen (PSA) screening.
INTRODUCTION
D ue to the availability of prostate-specific antigen (PSA) blood testing, high proportions of men in developed countries are screened for prostate cancer. Most PSA tests are ordered by general practitioners (GPs). [1] [2] [3] [4] [5] Yet PSA screening remains controversial. 6 Randomised controlled trials (RCTs) evaluating its efficacy are currently underway. 7, 8 Some of the adverse effects of PSA screening include the inadvertent detection and unnecessary treatment of indolent forms of prostate cancer and any iatrogenic effects. 6 In light of this, the US Preventive Services Taskforce concluded that: ' We are unable to determine the net benefit of screening because we cannot establish the presence and, if present, the magnitude of benefit from screening. We can establish the presence of potential harms. Whether screening would result in benefit, and whether that benefit would outweigh the attendant harms, is unknown. ' 6 Government and professional authorities agree that men should be fully apprised of the potential advantages and adverse effects of PSA screening. 9-14 However, men's knowledge of prostate cancer risk and their understanding of the pros and cons of PSA screening is suboptimal, precluding informed choice. 1, 4, 15 Surveys demonstrate that GPs are likely to initiate PSA screening without always disclosing relevant facts underpinning the controversy. 4, 15, 16 They do not always check that men understand the repercussions of their choices.
Men may regard the initiation of screening tests by their GP in a positive light, irrespective of the status of the available evidence of benefit or potential for harm. Men whose GPs encourage screening might perceive their GP as particularly diligent about their future health. Men diagnosed with prostate cancer as a result of undergoing a PSA screening test might be grateful that the cancer was detected early, even though its actual benefit in averting death is yet to be proven. 17 They are likely to have these views positively reinforced by family, friends, advocates and the media. 4, 15 Missed opportunities to diagnose prostate cancer, irrespective of the adverse effects likely to ensue, are negatively reinforced. 17 GPs remain anxious about medicolegal threats if they forgo the opportunity to initiate PSA screening, even when informed of the scientific uncertainty of its efficacy. 18 Few GPs perceive risk in recommending PSA screening to men, despite the potential cost to a man's quality of life in return for an uncertain benefit. 18 Furthermore, GPs are influenced to perform PSA screening in order to avert potential litigation. 18, 19 Yet quantification of patients' own views about GP liability for adverse consequences of screening has yet to be pursued.
We therefore included an empirical evaluation of men's views of GP liability within a larger study. We ascertained men's propensity to ascribe fault to GPs for missing an opportunity to detect cancer early via screening. We also assessed men's propensity to attribute responsibility for the iatrogenic consequences of screening. These views were elicited after and adjusted for receipt of information about the pros and cons of PSA screening.
METHODS

Participants and recruitment
As described in detail elsewhere, 20 households were randomly selected from an telephone directory of our local area in Sydney, Australia to recruit a representative sample of men aged 50-70 years. Men participated in two telephone interviews conducted approximately one month apart. Prior to the follow-up interview, men received one of three information packages about the pros and cons of PSA screening. 20 At the completion of this large study, we posed two scenarios to assess men's perceptions of GPs' professional responsibility for adverse consequences of PSA screening.
Measures
Medicolegal scenarios
Our medicolegal scenarios were posed to ascertain the extent to which GPs were perceived to be responsible for adverse consequences when advising either for or against PSA screening.
Scenario 1 requested participants to consider whether a GP is at fault when advising against testing in response to a patient's query. This patient is subsequently found to have prostate cancer (missed diagnosis Participants were asked to indicate whether or not the GP was 'at all at fault for not ordering a screening PSA blood test for Mr M 12 months ago' (Yes/No).
Scenario 2, in contrast, described a patient diagnosed with prostate cancer as a consequence of his GP advising for testing. In this scenario, the patient experiences side effects as a result of surgery (iatrogenic consequences). ᭜ Mr S is in his early 60s and visits his GP to have his blood pressure checked. This GP suggests that Mr S has a PSA test, although he has no symptoms of prostate cancer. The PSA test is abnormal and after more tests Mr S is diagnosed with early stage prostate cancer; the cancer is considered slow growing. This means that treatment may not affect how long Mr S lives, but Mr S has surgery in the hope of a cure. After surgery, Mr S is unable to have erections and has some leaking of the bladder, which requires him to wear pads. These side effects are permanent and distress Mr S.
Participants were asked to indicate whether or not they perceived the GP was 'at all responsible' for the patient's current situation (Yes/No).
Other measures
As described elsewhere, 20 we had already ascertained men's perceived susceptibility to and worry about prostate cancer, their previous participation in PSA screening, control preferences, interest in having the test in the next 12 months, knowledge about prostate cancer and the pros and cons of its early detection, decisional conflict, chance health locus of control and relevant demographic and health information ( Table 1 ).
Quality control of interviewing
A random sample of approximately 10% of each interviewer's telephone calls was monitored throughout interviewing to ensure interviewers adhered to the wording on the Computer Assisted Telephone Interview screen.
Statistical Analysis and Sample Size
Men's responses to the scenarios were the outcomes for analysis. Men who indicated 'yes' were compared with those who indicated 'no' for each scenario.
Multivariate analyses were then conducted to determine significant and independent predictors of an affirmative response to each scenario. Potential predictors considered for these analyses are shown in Table 1 . In addition, men's perceived susceptibility to prostate cancer, worry about developing prostate cancer, previous participation in PSA screening and interest in undergoing PSA screening during the next 12 months were also considered as potential predictors.
Variables univariately associated with outcomes at the p<0.25 level were selected for entry into the multivariate logistic regression model 21 using SPSS Version 12.0 (SPSS Inc, Chicago IL, USA). 22 We controlled for the type of information men had received prior to the follow-up interview in all multivariate analyses. 20 A non-automated backward selection procedure was adopted whereby the least significant term was removed in successive steps until only significant variables remained. A value of p<0.05 was set to determine significance.
Although predetermined by the larger study, 20 our sample size was sufficient to conduct a sub-group comparison of responses between men on categorical predictor variables given a power of 0.80 and an alpha level of 0.05. A sample size of 400 was sufficient to estimate proportions so that the 95% confidence intervals (CIs) for these estimates did not exceed ±5% of the true value. 23 Table 1 summarises relevant study and demographic data for the 405 participants in this medicolegal study. Age distribution was similar to that for men from the population defining the sampling frame. 20, 24 
RESULTS
Study sample
Men's perceptions of GP fault regarding missed diagnosis
When asked whether or not the GP was 'at all at fault', two thirds agreed (n=271, 66.9%), therefore ascribing fault to this GP who explained to the patient a test would not 'usually be ordered as there is no reason to think' the patient had a 'prostate problem' (Table 2) . Table 3 displays significant and independent predictors of an affirmative response to Scenario 1. Men who reported only fair or poor health were significantly and independently more likely to ascribe fault to this GP (adjusted odds ratio [AOR] 1.81; 95% CI 1.04-3.12; p=0.03). In addition, men with poorer knowledge were significantly and independently more likely to ascribe fault (AOR 0.98; 95% CI 0.97-0.99; p=0.002). Specifically, 55.3% of men who gave correct responses to >50% of the 14 knowledge items (as described elsewhere) 20 ascribed fault, compared with 76.7% of those who correctly responded to ≤50% ( Table 2 ).
Men's perceptions of GP responsibility regarding iatrogenic consequences
Only 15.8% (n=64) indicated the GP was 'at all responsible' for the adverse outcomes arising from treatment for prostate cancer detected through PSA screening initiated by the GP (Scenario 2; Table 2 ).
Men with higher scores on the Decisional Uncertainty subscale of the Decisional Conflict Scale were significantly and independently more likely to ascribe responsibility to the GP (AOR 1.19; 95% CI 1.04-1.37; p=0.01). Older men were also significantly and independently more likely to indicate that the GP was 'at all responsible' (AOR 1.05; 95% CI 1.00-1.10; p=0.04; Table 3 ).
DISCUSSION
A majority of men ascribe fault to GPs for missing an opportunity to diagnose prostate cancer early through screening. However, only a minority of men in this study were willing to ascribe responsibility to GPs for iatrogenic consequences of screening, even if that screening test had been initiated and recommended by the GP. This finding most likely reflects the psychological propensity for people to judge acts of omission more harshly than acts of commission, a finding that perhaps reflects a human tendency to feel regretful of missed opportunities. 32 Furthermore, data demonstrate that patients commonly instigate medicolegal claims for a doctor's failure to diagnose disease at an earlier time. 33 GPs rarely engage patients in discussions that would allow men to make informed decisions about PSA screening. 15, 16 While it is generally agreed that men undergoing tests need to be apprised of the pros and cons of PSA screening, informed refusal 34 is also being advocated so that men can be aware of the trade-offs involved in forgoing a PSA test. While our scenario for describing a missed diagnosis did not elaborate on the extent to which the patient was informed of the benefits and disadvantages of PSA screening, our findings demonstrated that men were less likely to ascribe fault if they were more knowledgeable about the pros and cons of screening. This indicates that men who are better informed may be better able to accept the trade-offs inherent in forgoing screening. Decision aids have now been proven to promote informed decision-making about PSA screening amongst men. 20, 21, 35 . Men have been shown to engage in heuristic processing when deciding about PSA screening. 36 For example, a man's fears about his risk of cancer may be exaggerated because of media hype, stories of other men's experiences and other similar influences. Encouraging systematic processing of information about PSA screening through the use of decision aids, however, may allow men to make better decisions that are not unduly influenced by such heuristic processes. In doing so, decision aids may also discourage men from ascribing fault to GPs for the tradeoffs inherent in PSA screening decisions. We also found that decisional conflict about PSA screening was positively associated with men's attributions of responsibility of GPs for iatrogenic consequences of screening. Studies evaluating decision aids about PSA screening have consistently demonstrated that information reduces decisional conflict. Therefore, this finding suggests that GPs may better manage their risk of being held liable if they utilise these resources and assist their male patients to better resolve decisional conflict about PSA screening. However, the impact decision aids have on men's propensity to attribute liability for missed diagnoses remains untested. 35 Men's views on GP fault and responsibility for adverse consequences of PSA screening may be a useful endpoint in future research.
Our analysis also suggested other factors may predict men's attribution of fault or responsibility for adverse screening outcomes. For example, men in poorer health were more likely to ascribe fault to the GP for missing an opportunity to diagnose prostate cancer. Men in poorer health may be accustomed to medical tests that lead to alleviation of symptoms or conditions and hence may come to expect greater vigilance on the part of doctors. Compared with younger men, older men were more likely to indicate that GPs were responsible for iatrogenic consequences of PSA screening, indicating that older men may place greater value on quality of life, or alternatively are more aware of the impact that side effects associated with treatment have on quality of life.
Public education could better target men's tendency to ascribe fault to GPs when they miss an opportunity to diagnose prostate cancer early through PSA screening, even though the corollary of potential iatrogenic consequences is perceived as less blameworthy. As decisional conflict and knowledge were found to predict attribution of fault, evidence-based information may reduce the medicolegal volatility of this controversy.
